Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 65

Sort by

Sort Order Select

Journal Articles

Variability in Bleeding Phenotype in Type 3 VWD Families

Pamela A Christopherson, Veronica H Flood, MD, Sandra L Haberichter, PhD, Joan Cox Gill, MD, Robert R Montgomery, MD, Zimmerman Program Investigators

Blood (2018) 132 (Supplement 1): 2466.

https://doi.org/10.1182/blood-2018-99-112961

Published: 2018

Journal Articles

Bleeding Patterns in Type I VWD in Effect of VWF Levels: An Individual Participant Data Meta-Analysis of Three Cohorts

Alberto Tosetto, Pamela A Christopherson, Jeroen C.J. Eikenboom, MD, Julie Grabell, CCRP, Paula D. James, MD, Robert R Montgomery, MD, Ian Peake, PhD, Mariana Silva, MD FRCPC, Zimmerman Program Investigators

Blood (2018) 132 (Supplement 1): 1180.

https://doi.org/10.1182/blood-2018-99-115728

Published: 2018

Journal Articles

A Murine Model of Type 2N VWD Was Developed By CRISPR/Cas9 Gene Editing and Recapitulates Human Type 2N VWD

Robert R Montgomery, MD, Scot A Fahs, Jeremy G Mattson, Hartmut Weiler, PhD, Qizhen Shi, MD

Blood (2018) 132 (Supplement 1): 221.

https://doi.org/10.1182/blood-2018-99-110324

Published: 2018

Journal Articles

The Severe Spontaneous Bleeding Phenotype in a Novel Hemophilia a Rat Model with an Inversion Mutation Is Rescued By Platelet-Targeted FVIII Expression

Qizhen Shi, MD, Jeremy G Mattson, Scot A Fahs, Robert R Montgomery, MD

Blood (2018) 132 (Supplement 1): 219.

https://doi.org/10.1182/blood-2018-99-112165

Published: 2018

Journal Articles

Von Willebrand Factor Binding to Myosin Assists in Coagulation

Veronica H Flood, MD, Tricia L Slobodianuk, BS, Daniel A Keesler, BS, Hannah Lohmeier, Scot A Fahs, Robert R Montgomery, MD

Blood (2018) 132 (Supplement 1): 22.

https://doi.org/10.1182/blood-2018-99-113105

Published: 2018

Journal Articles

Prospective Diagnosis of VWD in a Large Cohort of Patients with Bleeding Symptoms through the Zimmerman Program

Veronica H Flood, MD, Pamela A Christopherson, Joan Cox Gill, MD, Kenneth Dale Friedman, MD, Sandra L Haberichter, PhD, Jorge Di Paola, MD, Paula D. James, MD, Janna M. Journeycake, MD, Steven R. Lentz, MD PhD, Cindy A. Leissinger, MD, Margaret V. Ragni, MD MPH, Madhvi Rajpurkar, MD, Jonathan C. Roberts, MD, Amy Shapiro, Robert F. Sidonio, Robert R Montgomery, MD, Thomas C. Abshire, MD

Blood (2018) 132 (Supplement 1): 979.

https://doi.org/10.1182/blood-2018-99-110650

Published: 2018

Journal Articles

Critical Extracellular Matrix Proteins Besides Collagen Bind Von Willebrand Factor

Daniel A Keesler, BS, Caroline E Kochelek, BS, Tricia L Slobodianuk, BS, Robert R. Montgomery, MD, Veronica H Flood, MD

Blood (2017) 130 (Supplement 1): 2309.

https://doi.org/10.1182/blood.V130.Suppl_1.2309.2309

Published: 2017

Journal Articles

Genotype-Phenotype Relationship and the Role of Alloantibodies in Type 3 VWD in the Zimmerman Program

Pamela A Christopherson, Crystal L Perry, Daniel B. Bellissimo, PhD, Veronica H Flood, MD, Joan Cox Gill, MD, Sandra L Haberichter, PhD, Robert R. Montgomery, MD, Zimmerman Program Investigators

Blood (2017) 130 (Supplement 1): 19.

https://doi.org/10.1182/blood.V130.Suppl_1.19.19

Published: 2017

Journal Articles

Contribution of Select ISTH-BAT Subscores to the Total Score in Type 1 VWD

Jessica Garcia, MD, Pamela A Christopherson, Veronica H Flood, MD, Joan Cox Gill, MD, Robert R. Montgomery, MD, Paula D. James, MD, Pippa Simpson, PhD, Liyun Zhang, MS, Thomas C. Abshire, MD, Zimmerman Program Investigators

Blood (2017) 130 (Supplement 1): 1075.

https://doi.org/10.1182/blood.V130.Suppl_1.1075.1075

Published: 2017

Journal Articles

Quantitative Analysis of Von Willebrand Factor (VWF) Multimers in Von Willebrand Disease (VWD) Patients Recruited through the Zimmerman Program for the Molecular and Clinical Biology of VWD

Sandra L Haberichter, PhD, Pamela A Christopherson, Veronica H Flood, MD, Joan Cox Gill, MD, Kenneth Dale Friedman, MD, Robert R. Montgomery, MD

Blood (2017) 130 (Supplement 1): 1085.

https://doi.org/10.1182/blood.V130.Suppl_1.1085.1085

Published: 2017

Journal Articles

Expression of Sequence Variants Identified in Type 1 VWD Subjects in the Zimmerman Program Study Reveals Defects in VWF Secretion and Multimerization

Azza Abdelaal, MD M.S., David Jakab, B.S., Pamela A Christopherson, Robert R Montgomery, MD, Sandra L Haberichter, PhD

Blood (2016) 128 (22): 1398.

https://doi.org/10.1182/blood.V128.22.1398.1398

Published: 2016

Journal Articles

Humanized Von Willebrand Factor-Glycoprotein Ibα Interaction in Mouse Models of Hemostasis and Thrombosis

Sachiko Kanaji, MD PhD, Jennifer N Orje, Yuichi Kamikubo, PhD, Taisuke Kanaji, MD PhD, Jeremy Mattson, Alessandro Zarpellon, PhD, Scot A. Fahs, Rashmi Sood, PhD, Sandra L Haberichter, PhD, Zaverio M. Ruggeri, MD, Robert R Montgomery, MD

Blood (2016) 128 (22): 558.

https://doi.org/10.1182/blood.V128.22.558.558

Published: 2016

Journal Articles

The Impact of VWF on FVIII Immune Responses in Hemophilia a Mice with Pre-Existing Anti-FVIII Immunity

Juan Chen, PhD, Jocelyn A. Schroeder, Xiaofeng Luo, MD PhD, Robert R. Montgomery, MD, Qizhen Shi, MD PhD

Blood (2016) 128 (22): 84.

https://doi.org/10.1182/blood.V128.22.84.84

Published: 2016

Journal Articles

Identification of Copy Number Variants in Type 1 and Type 3 VWD by aCGH in the Zimmerman Program

Pamela A Christopherson, Rupa A Udani, PhD, Crystal Perry, BS, Daniel B Bellissimo, PhD, Sandra L Haberichter, PhD, Veronica H Flood, MD, Kenneth D Friedman, MD, Joan Cox Gill, MD, Robert R. Montgomery, MD, Zimmerman Program Investigators

Blood (2016) 128 (22): 872.

https://doi.org/10.1182/blood.V128.22.872.872

Published: 2016

Journal Articles

Von Willebrand Factor (VWF) Propeptide and Factor VIII (FVIII) Levels Identify the Contribution of Decreased Synthesis and/or Increased Clearance Mechanisms in the Pathogenesis of Type 1 Von Willebrand Disease (VWD) in the Zimmerman Program

Sandra L Haberichter, PhD, Pamela A Christopherson, Veronica H Flood, MD, Joan Cox Gill, MD, Kenneth D Friedman, MD, Robert R. Montgomery, MD

Blood (2016) 128 (22): 874.

https://doi.org/10.1182/blood.V128.22.874.874

Published: 2016

Journal Articles

Domain Distribution of Type 1 VWD Sequence Variants and Impact on Clinical and Laboratory Phenotype in the Zimmerman Program

Pamela A Christopherson, Veronica H Flood, MD, Sandra L Haberichter, PhD, Daniel B Bellissimo, PhD, Kenneth D Friedman, MD, Joan Cox Gill, MD, Rupa A Udani, PhD, Robert R Montgomery, MD

Blood (2015) 126 (23): 758.

https://doi.org/10.1182/blood.V126.23.758.758

Published: 2015

Journal Articles

Quantitative Measurement of VWF Binding to the Platelet Integrin αIIbβ3 - Abnormalities Identified in Individuals with VWD

Robert R. Montgomery, MD, Veronica H Flood, MD, Jieqing Zhu, PhD, Pamela A Christopherson, Peter J. Newman, PhD, Daniel W. Bougie, PhD, Patti Morateck

Blood (2015) 126 (23): 1107.

https://doi.org/10.1182/blood.V126.23.1107.1107

Published: 2015

Journal Articles

The Impact of GPIba on the Efficacy of Platelet-Targeted FVIII Gene Therapy in Hemophilia a with Pre-Existing Anti-FVIII Immunity

Juan Chen, PhD, Jocelyn Schroeder, Xiaofeng Luo, MD, Robert R Montgomery, MD, Qizhen Shi, MD PhD

Blood (2015) 126 (23): 1067.

https://doi.org/10.1182/blood.V126.23.1067.1067

Published: 2015

Journal Articles

A Native Whole Blood Thrombin Generation Assay Allows Discrimination of Whole Blood Samples with FVIII Levels below 1%

Christina K Baumgartner, Jonathan C Roberts, Paula M Jacobi, Sandra L Haberichter, Qizhen Shi, Robert R. Montgomery, MD

Blood (2014) 124 (21): 4215.

https://doi.org/10.1182/blood.V124.21.4215.4215

Published: 2014

Journal Articles

A Von Willebrand Factor (VWF) Functional Screening Assay and Its Correlation with Conventional Clinical Assays of VWF Function

Jonathan C Roberts, Pamela A Christopherson, Patti A Morateck, Ke Yan, Raymond G Hoffmann, Joan Cox Gill, MD, Robert R Montgomery, MD, The Zimmerman Program Investigators

Blood (2014) 124 (21): 4239.

https://doi.org/10.1182/blood.V124.21.4239.4239

Published: 2014

NARROW

Variability in Bleeding Phenotype in Type 3 VWD Families

Bleeding Patterns in Type I VWD in Effect of VWF Levels: An Individual Participant Data Meta-Analysis of Three Cohorts

A Murine Model of Type 2N VWD Was Developed By CRISPR/Cas9 Gene Editing and Recapitulates Human Type 2N VWD

The Severe Spontaneous Bleeding Phenotype in a Novel Hemophilia a Rat Model with an Inversion Mutation Is Rescued By Platelet-Targeted FVIII Expression

Von Willebrand Factor Binding to Myosin Assists in Coagulation

Prospective Diagnosis of VWD in a Large Cohort of Patients with Bleeding Symptoms through the Zimmerman Program

Critical Extracellular Matrix Proteins Besides Collagen Bind Von Willebrand Factor

Genotype-Phenotype Relationship and the Role of Alloantibodies in Type 3 VWD in the Zimmerman Program

Contribution of Select ISTH-BAT Subscores to the Total Score in Type 1 VWD

Quantitative Analysis of Von Willebrand Factor (VWF) Multimers in Von Willebrand Disease (VWD) Patients Recruited through the Zimmerman Program for the Molecular and Clinical Biology of VWD

Expression of Sequence Variants Identified in Type 1 VWD Subjects in the Zimmerman Program Study Reveals Defects in VWF Secretion and Multimerization

Humanized Von Willebrand Factor-Glycoprotein Ibα Interaction in Mouse Models of Hemostasis and Thrombosis

The Impact of VWF on FVIII Immune Responses in Hemophilia a Mice with Pre-Existing Anti-FVIII Immunity

Identification of Copy Number Variants in Type 1 and Type 3 VWD by aCGH in the Zimmerman Program

Von Willebrand Factor (VWF) Propeptide and Factor VIII (FVIII) Levels Identify the Contribution of Decreased Synthesis and/or Increased Clearance Mechanisms in the Pathogenesis of Type 1 Von Willebrand Disease (VWD) in the Zimmerman Program

Domain Distribution of Type 1 VWD Sequence Variants and Impact on Clinical and Laboratory Phenotype in the Zimmerman Program

Quantitative Measurement of VWF Binding to the Platelet Integrin αIIbβ3 - Abnormalities Identified in Individuals with VWD

The Impact of GPIba on the Efficacy of Platelet-Targeted FVIII Gene Therapy in Hemophilia a with Pre-Existing Anti-FVIII Immunity

A Native Whole Blood Thrombin Generation Assay Allows Discrimination of Whole Blood Samples with FVIII Levels below 1%

A Von Willebrand Factor (VWF) Functional Screening Assay and Its Correlation with Conventional Clinical Assays of VWF Function

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only